Title: Endomyocardial fibrosis in
Sudan: clinical and echocardiographic features
Authors: Siddiq Ibrahim Khalil, Suha Khalil,
Salma El Tigani, Hanan A Saad
From: Cardiovascular Journal of Africa, Vol 28,
Issue 4, July/August
Published: 2017
Pages: 208-214
Full text: Click here to order
»
Full text:
Click here to read online »
Full text: Click here to
read via Sabinet » (Login Required)
DOI Number:10.5830/CVJA-2016-079
DOI Citation Reference Link:
dx.doi.org/10.5830/CVJA-2016-079
Objective: Endomyocardial fibrosis (EMF) is a
rare disease and is often an underdiagnosed and
forgotten cardiomyopathy. The objective of this
study was to document the current frequency of
EMF in Sudan by defining and selecting cases
from patients attending the echocardiography
laboratory. Additionally we aimed to create an
EMF registry for Sudan.
Methods: The study started in January 2007 and
is on-going. All the patients attending our
echocardiography clinics in four different
hospitals in Khartoum, Sudan, were included.
Transthoracic echocardiography was used as the
main diagnostic and selection tool. The
diagnosis of EMF was based on predefined
criteria and definitions, and was further
supported by additional clinical, ECG,
laboratory and chest X-ray findings.
Results: Out of 4 332 cases studied, 23 (0.5%)
were found to have features of EMF. Females
constituted 52% and the age range was 24 to 67
years. All patients presented with dyspnoea
grades III–IV. Advanced heart failure with gross
fluid overload was seen in 54% of cases and
ascites was seen in 30%. EMF was biventricular
in 53%, left ventricular in 29% and right
ventricular in 18% of cases. Apical and
ventricular wall fibrosis was found in all
cases, followed by atrial enlargement,
atrioventricular valve incompetence, ventricular
cavity obliteration, restrictive flow pattern
and pericardial effusion. Additional
echocardiographic features are defined and
discussed.
Conclusion: Although a rare disease, cases of
EMF can be identified in Sudan if a high index
of suspicion is observed. New echocardiographic
features of ventricular wall layering,
endocardial fibrous shelf and
endomyocardiopericarial fibrosis were identified
and are discussed.
Title: The changing spectrum of rheumatic mitral regurgitation in
Soweto, South Africa
Authors:Ruchika Meel, Ferande Peters, Elena
Libhaber, Mohammed Rafique Essop
From: Cardiovascular Journal of Africa, Vol 28,
Issue 4, July/August
Published: 2017
Pages: 215-220
Full text: Click here to order
»
Full text:
Click here to read online »
Full text: Click here to
read via Sabinet » (Login Required)
DOI Number:10.5830/CVJA-2016-086
DOI Citation Reference Link:
dx.doi.org/10.5830/CVJA-2016-086
Objectives: To determine the clinical and
echocardiographic characteristics of contemporary patients with rheumatic mitral
regurgitation (MR) at Chris Hani Baragwanath Academic Hospital.
Methods: This prospective, cross-sectional study included 84 patients with
isolated moderate or severe rheumatic MR who underwent clinical and
echocardiographic assessment.
Results: Mean age of the patients was 44 ± 15.3 years (84% females). Acute
rheumatic fever was rare. Hypertension and HIV were present in 52 and 26%,
respectively. Echocardiography showed leaflet thickening and calcification,
restricted motion and subvalvular disease in 41, 25 and 34%, respectively.
Carpentier IIIa leaflet dysfunction occurred in 80% of patients and leaflet
prolapse was seen in only 20%. These findings contrast with the previous
literature, where patients were younger, they had rheumatic carditis and there
were no co-morbidities. Leaflets were pliable, isolated leaflet prolapse was
common and commissural fusion was absent.
Conclusion: Contemporary patients with rheumatic MR were older, fewer had
rheumatic fever and there were more co-morbidities. Echocardiographic features
had evolved to greater leaflet thickening, calcification and reduced motion with
minimal prolapse. These findings may have important implications for surgical
management of this disease.
Title: The prevalence and
radiological findings of pulmonary embolism in
HIV-positive patients referred for computed
tomography pulmonary angiography in the Western
Cape of South Africa
Authors: Raksha Ramlakhan, Savvas Andronikou,
Ashmitha Rajkumar
From: Cardiovascular Journal of Africa, Vol 28,
Issue 4, July/August
Published: 2017
Pages: 221–228
Full text: Click here to order
»
Full text:
Click here to read online »
Full text: Click here to
read via Sabinet » (Login Required)
DOI Number: 10.5830/CVJA-2016-083
DOI Citation Reference Link:
dx.doi.org/10.5830/CVJA-2016-083
Aim: To provide imaging data and report
associations between human immunodeficiency
virus (HIV), tuberculosis (TB) and pulmonary
embolism (PE) in a South African population that
underwent computed tomography pulmonary
angiography (CTPA) for suspected PE.
Methods: A validated Qanadli severity scoring
system for PE was used for 164 CTPA scans, and
parenchymal, pleural and cardiovascular
complications were reported. Serological
confirmation of HIV testing and microbiological
confirmation of TB were recorded.
Results: Prevalence of PE in the CTPA population
was 26% (95% CI: 19.67–33.65%). HIV-positive
prevalence in patients with PE was 67% (95% CI:
48.17–82.04%), however it was not statistically
significantly different when compared with the
patients without PE (p = 1). HIV-positive
patients had more extensive partial thrombus in
the right middle lobe (p = 0.045), but no other
differences when compared with HIV-negative
patients. TB prevalence in patients with PE was
57% (95% CI: 34.49–76.81%). This was
statistically significantly different when
compared with the patients without PE (p = 0.073
at the 10% level). Prevalence of TB co-morbidity
in the HIV-positive group with proven PE was 71%
(95% CI: 41.90– 91.61%), however there was no
statistically significant difference in
comparison with the HIV-negative patients with
TB and PE (p= 0.305).
Conclusion: The high number of patients
presenting for CTPA who were HIV infected (and
also infected with TB) highlights that PE
evaluation should include severity/extent of the
disease, as these patients may have more severe
disease in specific lung lobes. The use of a
validated scoring system, such as the Qanadli
score, when reporting PE may have a profound
effect on patient risk stratification,
management and prognosis and would also provide
a system for collecting larger volumes of data
for analysis.
Title: Nuclear cardiology practices and radiation exposure in
Africa: results from the IAEA Nuclear Cardiology Protocols Study (INCAPS)
Authors: Salah E Bouyoucef, Mathew Mercuri,
Thomas NB Pascual, Adel H Allam, Mboyo Vangu, João V Vitola, Nathan Better,
Ganesan Karthikeyan, John J Mahmarian, Madan M Rehani, Ravi Kashyap, Maurizio
Dondi, Diana Paez, Andrew J Einstein, for the INCAPS investigators group
From: Cardiovascular Journal of Africa,
Vol 28, Issue 4, July/August
Published: 2017
Pages: 129-234
Full text: Click here to order
»
Full text:
Click here to read online »
Full text: Click here to
read via Sabinet » (Login Required)
DOI Number: 10.5830/CVJA-2016-091
DOI Citation Reference Link:
dx.doi.org/10.5830/CVJA-2016-091
Objective: While nuclear myocardial perfusion
imaging (MPI) offers many benefits to patients with known or suspected
cardiovascular disease, concerns exist regarding radiationassociated health
effects. Little is known regarding MPI practice in Africa. We sought to
characterise radiation doses and the use of MPI best practices that could
minimise radiation in African nuclear cardiology laboratories, and compare these
to practice worldwide.
Methods: Demographics and clinical characteristics were collected for a
consecutive sample of 348 patients from 12 laboratories in six African countries
over a one-week period from March to April 2013. Radiation effective dose (ED)
was estimated for each patient. A quality index (QI) enumerating adherence to
eight best practices, identified a priori by an IAEA expert panel, was
calculated for each laboratory. We compared these metrics with those from 7 563
patients from 296 laboratories outside Africa.
Results: Median (interquartile range) patient ED in Africa was similar to that
of the rest of the world [9.1 (5.1–15.6) vs 10.3 mSv (6.8–12.6), p = 0.14],
although a larger proportion of African patients received a low ED, ≤ 9 mSv
targeted in societal recommendations (49.7 vs 38.2%, p < 0.001). Bestpractice
adherence was higher among African laboratories (QI score: 6.3 ± 1.2 vs 5.4 ±
1.3, p = 0.013). However, median ED varied significantly among African
laboratories (range: 2.0–16.3 mSv; p < 0.0001) and QI range was 4–8.
Conclusion: Patient radiation dose from MPI in Africa was similar to that in the
rest of the world, and adherence to best practices was relatively high in
African laboratories. Nevertheless there remain opportunities to further reduce
radiation exposure to African patients from MPI.
Title: Pilot study of risk factors
associated with cardiovascular disease in
northern and southern Cameroonians
Authors: Jeanne Durendale Chiadak, Jason Perret,
Hilaire Macaire Womeni, Jules Roger Kuiaté,
Pierre Cullus, Christelle Senterre, Christine
Delporte
From: Cardiovascular Journal of Africa, Vol 28,
Issue 4, July/August
Published: 2017
Pages: 235-341
Full text: Click here to order
»
Full text:
Click here to read online »
Full text: Click here to
read via Sabinet » (Login Required)
DOI Number: 10.5830/CVJA-2016-094
DOI Citation Reference Link:
dx.doi.org/10.5830/CVJA-2016-094
Aim: The aim of the study was to evaluate
whether the risk factors for cardiovascular
disease (CVD) are similar in the northern and
southern regions of Cameroon.
Methods: The participants answered a
questionnaire concerning their lifestyle.
Anthropometric and blood pressure measurements
were evaluated in 192 individuals and
biochemical parameters in 50 randomly selected
volunteers.
Results: Northerners displayed low alcohol and
tobacco consumption, little practice of sport
but physically demanding professions, and
consumption of soybean, refined palm and other
polyunsaturated oils. Southerners consumed
alcohol, practiced sport, had intellectually
based professions, and consumed crude and
refined palm oils. Waist circumference and body
mass index were higher in the southerners
compared to the northerners. Blood glucose
levels, and systolic and diastolic blood
pressures were higher among the northerners than
the southerners. Among the southerners, there
were positive correlations between total
cholesterol levels and systolic or diastolic
blood pressure, low-density lipoprotein
cholesterol and blood glucose levels or
diastolic blood pressure, triglyceride levels
and systolic blood pressure.
Conclusion: Providing region-adapted,
health-related advice for northern and southern
Cameroonians would contribute to reducing risk
factors for CVD.
Title: A programme to increase appropriate usage of benzathine
penicillin for management of streptococcal pharyngitis and rheumatic heart
disease in Zambia
Authors: Aidan Long, Joyce Chipili Lungu,
Elizabeth Machila, Sherri Schwaninger, Jonathan Spector, Brigitta Tadmor, Mark
Fishman, Bongani M Mayosi, John Musuku
From: Cardiovascular Journal of Africa, Vol 28,
Issue 4, July/August
Published: 2017
Pages: 242–247
Full text: Click here to order
»
Full text:
Click here to read online »
Full text: Click here to
read via Sabinet » (Login Required)
DOI Number: 10.5830/CVJA-2017-002
DOI Citation Reference Link:
dx.doi.org/10.5830/CVJA-2017-002
Abstract: Rheumatic heart disease is highly
prevalent and associated with substantial morbidity and mortality in many
resourcepoor areas of the world, including sub-Saharan Africa. Primary and
secondary prophylaxis with penicillin has been shown to significantly improve
outcomes and is recognised to be the standard of care, with intra-muscular
benzathine penicillin G recommended as the preferred agent by many technical
experts. However, ensuring compliance with therapy has proven to be challenging.
As part of a public–private partnership initiative in Zambia, we conducted an
educational and access-to-medicine programme aimed at increasing appropriate use
of benzathine penicillin for the prevention and management of rheumatic heart
disease, according to national guidelines. The programme was informed early on
by identification of potential barriers to the administration of injectable
penicillin, which included concern by health workers about allergic events. We
describe this programme and report initial signs of success, as indicated by
increased use of benzathine penicillin. We propose that a similar approach may
have benefits in rheumatic heart disease programmes in other endemic regions.
Title: Clinical presentation and outcomes of patients with acute
rheumatic fever and rheumatic heart disease seen at a tertiary hospital setting
in Port Elizabeth, South Africa
Authors: Zongezile Masonwabe Makrexeni, Lungile
Pepeta
From: Cardiovascular Journal of Africa, Vol 28,
Issue 4, July/August
Published: 2017
Pages: 248-250
Full text: Click here to order
»
Full text:
Click here to read online »
Full text: Click here to
read via Sabinet » (Login Required)
DOI Number: 10.5830/CVJA-2017-019
DOI Citation Reference Link:
dx.doi.org/10.5830/CVJA-2017-019
Background: The incidence of acute rheumatic
fever (ARF) and rheumatic heart disease (RHD) has waned in Western countries,
however that is not the situation in developing nations.
Methods: Records were reviewed of patients from the Eastern Cape municipal
districts who presented to the Paediatric Cardiology Unit with ARF and RHD from
January 2008 to August 2015.
Results: Total of 56 patients with ARF/RHD was reviewed. The majority of
patients (n = 52) presented for the first time with RHD. Four patients presented
with ARF and two had recurrent ARF. Six patients presented with a combination of
RHD and congenital heart disease. Twenty-three patients were operated on for
chronic rheumatic valve disease, with good outcomes.
Conclusion: The true burden of ARF/RHD is unknown in the Eastern Cape.
Prospective studies are needed to accurately determine the prevalence of RHD in
this province.
Title: Primary care in the prevention, treatment and control of
cardiovascular disease in sub-Saharan Africa Authors: Dike B Ojji, Kim Lamont,
Olubunmi I Ojji, Bibiana Nonye Egenti, Karen Sliwa
From: Cardiovascular Journal of Africa, Vol 28,
Issue 4, July/August
Published: 2017
Pages: 251-256
Full text: Click here to order
»
Full text:
Click here to read online »
Full text: Click here to
read via Sabinet » (Login Required)
DOI Number: 10.5830/CVJA-2016-082
DOI Citation Reference Link:
dx.doi.org/10.5830/CVJA-2016-082
Abstract: Cardiovascular disease (CVD) is the
frontrunner in the disease spectrum of sub-Saharan Africa, with stroke and
ischaemic heart disease ranked seventh and 14th as leading causes of death,
respectively, on this sub-continent. Unfortunately, this region is also
grappling with many communicable, maternal, neonatal and nutritional disorders.
Limited resources and the high cost of CVD treatment necessitate that primary
prevention should have a high priority for CVD control in sub- Saharan Africa.
One major challenge of such an approach is how to equip primary care to respond
promptly and effectively to this burden. We present a practical approach on how
primary care in sub-Saharan Africa could effectively address the prevention,
treatment and control of CVD on the subcontinent. For effective prevention,
control and treatment of CVD in sub-Saharan Africa, there should be strategic
plans to equip primary care clinics with well-trained allied healthcare workers
who are supervised by physicians.
Title: Reviewing the causes of
electrocardiographic pauses Authors: Charle Viljoen, Robert Smith,
Ashley Chin
From: Cardiovascular Journal of Africa, Vol 28,
Issue 4, July/August
Published: 2017
Pages: 257-260
Full text: Click here to order
»
Full text:
Click here to read online »
Full text: Click here to
read via Sabinet » (Login Required)
DOI Number: 10.5830/CVJA-2017-041
DOI Citation Reference Link:
dx.doi.org/10.5830/CVJA-2017-041
Abstract: The electrocardiographic term ‘pause’
refers to the prolonged R-R interval that
represents the interruption in ventricular
depolarisation. This article presents a case of
sinus node dysfunction and provides a diagnostic
approach to pauses on the ECG..
Title: Roadmap to achieve 25% hypertension control in Africa by 2025 Authors: Anastase Dzudie, Brian Rayner, Dike Ojji, Aletta E Schutte,
Marc Twagirumukiza, Albertino Damasceno, Seringe Abdou Ba, Abdoul Kane, Euloge
Kramoh, Jean Baptiste Anzouan Kacou, Basden Onwubere, Ruth Cornick, Karen Sliwa,
Benedict Anisiuba, Ana Olga Mocumbi, Elijah Ogola, Mohamed Awad, George Nel,
Harun Otieno, Ali Ibrahim Toure, Samuel Kingue, Andre Pascal Kengne, Pablo
Perel, Alma Adler, Neil Poulter, Bongani Mayosi, on behalf of the PASCAR task
force on hypertension
From: Cardiovascular Journal of Africa, Vol 28,
Issue 4, July/August
Published: 2017
Pages: 261–272
Full text: Click here to order
»
Full text:
Click here to read online »
Full text: Click here to
read via Sabinet » (Login Required)
DOI Number: 10.5830/CVJA-2017-040
DOI Citation Reference Link:
dx.doi.org/10.5830/CVJA-2017-040
Background and aim: The Pan-African Society of
Cardiology (PASCAR) has identified hypertension as the highest area of priority
for action to reduce heart disease and stroke on the continent. The aim of this
PASCAR roadmap on hypertension was to develop practical guidance on how to
implement strategies that translate existing knowledge into effective action and
improve detection, treatment and control of hypertension and cardiovascular
health in sub-Saharan Africa (SSA) by the year 2025.
Methods: Development of this roadmap started with the creation of a consortium
of experts with leadership skills in hypertension. In 2014, experts in different
fields, including physicians and non-physicians, were invited to join. Via
faceto- face meetings and teleconferences, the consortium made a situation
analysis, set a goal, identified roadblocks and solutions to the management of
hypertension and customised the World Heart Federation roadmap to Africa.
Results: Hypertension is a major crisis on the continent but very few
randomised, controlled trials have been conducted on its management. Also, only
25.8% of the countries have developed or adopted guidelines for the management
of hypertension. Other major roadblocks are either government and health-system
related or healthcare professional or patient related. The PASCAR hypertension
task force identified a 10-point action plan to be implemented by African
ministries of health to achieve 25% control of hypertension in Africa by 2025.
Conclusions: Hypertension affects millions of people in SSA and if left
untreated, is a major cause of heart disease and stroke. Very few SSA countries
have a clear hypertension policy. This PASCAR roadmap identifies practical and
effective solutions that would improve detection, treatment and control of
hypertension on the continent and could be implemented as is or adapted to
specific national settings.
Title: Illuminating the pathway for the next generation of
cardiovascular medicine practitioners and researchers: Highlights of the Joint
PASCAR–SCC clinical symposium on hypertension and heart failure, Cameroon
Authors:Martin H Abanda, Anastase Dzudie, Ba
Hamadou, Yves Monkam, Henry Luma, Marie Solange Douala, Loryane Nganhyim,
Bonaventure S Dzekem, Theophile N Nana, George Nel, Ana O Mocumbi, Simon
Stewart, Karen Sliwa, Eugene Belley Priso
From: Cardiovascular Journal of Africa, Vol 28,
Issue 4, July/August
Published: 2017
Pages: 274-276
Full text: Click here to order
»
Full text:
Click here to read online »
Full text: Click here to
read via Sabinet » (Login Required)
Abstract: The Pan-African Society of Cardiology
roadmap aims to achieve a 25% control of hypertension by the year 2025. Whether
this is attainable or not depends largely on the capacity of healthcare
providers and policy makers to address the rising prevalence of hypertension and
its complications, including heart failure. Task sharing is fundamental in
optimising hypertension control.
The Clinical Research Education, Networking and Consultancy (CRENC) engaged with
the Pan-African Society of Cardiology (PASCAR) and the Cameroon Cardiac Society
(SCC) in a joint hypertension and heart failure symposium at the Douala General
Hospital in 2016. The primary aims were to foster clinical research in
cardiovascular medicine by raising awareness on cardiovascular diseases, to
provide evidence-based training of an international standard, to encourage the
conduction and dissemination of high-quality research, and to build programmes
for continuing medical education. The secondary aim was to potentiate the 2nd
Douala Research and Scientific Days.
The symposium, which featured didactic lectures interspaced with oral/poster
abstract presentations and a clinical visit, culminated in the launching of the
book Heart of Africa, and the Young Investigator award. It is hoped that these
served to capacitate existing cardiovascular structures, breed the next
generation of cardiovascular physicians and researchers, and imprint a trail of
clinical research excellence to be emulated in Cameroon and beyond.
Title: An unusual case of aorta–right atrial tunnel with windsock
aneurysm: imaging, diagnosis and treatment
Authors: Shehzaadi Aneesah Mohamed Khan, Leonie
Scholtz, F Adriaan Snyders, Johan de Villiers
From: Cardiovascular Journal of Africa, Vol 28,
Issue 4, July/August
Published: 2017
Pages: e1-e5
Full text: Click here to order
»
Full text:
Click here to read online »
Full text: Click here to
read via Sabinet » (Login Required)
DOI Number: 10.5830/CVJA-2016-073
DOI Citation Reference Link:
dx.doi.org/10.5830/CVJA-2016-073
Abstract: The first successfully diagnosed and
treated case of aorta– right atrial tunnel was reported by Coto et al. in 1980.
The most common cause of aorta–right atrial tunnel is a ruptured aneurysm of the
sinus of Valsalva. Sinus of Valsalva aneurysms had been reported as early as
1840 by Thurnam; these were diagnosed at autopsy. With the advances in
radiology, many cases of aorta–right atrial tunnel have been reported since
then, each with its own subtle variations.
We report on a unique case of aorta–right atrial tunnel with a windsock aneurysm
in the right atrium. A 55-year old male presented with abdominal pain and the
chest X-ray revealed cardiomegaly. On further investigation with
echocardiography and computed tomography angiography, there was an incidental
aorta–right atrial tunnel with a windsock aneurysm in the right atrium. He was
treated successfully with surgery. A similar case has been reported only once
before by Iyisoy et al. in 2014.
Title: Management of a complicated redo giant dissecting aortic
aneurysm
Authors: Ibrahim Kara, Alper Erkin, Halil
Ibrahim Erkengel, Kıyasettin Asil
From: Cardiovascular Journal of Africa, Vol 28,
Issue, 4, July/August
Published: 2017
Pages:e6-e8
Full text: Click here to order
»
Full text:
Click here to read online »
Full text: Click here to
read via Sabinet » (Login Required)
DOI Number: 10.5830/CVJA-2016-084
DOI Citation Reference Link:
dx.doi.org/10.5830/CVJA-2016-084
Abstract: Giant aortic aneurysm is defined as an
aneurysm of the aorta of greater than 10 cm in diameter. This rare condition is
associated with a high risk of morbidity and mortality and it may lead to fatal
complications such as rupture and/or dissection if not managed with proper
surgical planning and expertise. Other than atherosclerosis, the main causes of
giant ascending aortic aneurysms include Marfan and Ehlers–Danhlos syndromes.
Herein we report on a young male patient who had had an aortic valve replacement
five years earlier due to a bicuspid aortic valve leading to aortic failure,
accompanied by aortic coarctation. He had an aneurysmal expansion rate of 1.81
cm/year to reach a final aneurysmal diameter of 13.25 cm, which, to our
knowledge, represents the largest size ever reported in the literature for such
lesions, and in which the redo and aneurysmal wall were adjacent to the sternal
margins.
Title: Left ventricular haematoma
mimicking lateral wall myocardial infarction
secondary to percutaneous coronary intervention
Authors: Omer Senarslan, Necdet Batuhan Tamci,
Umut Hasan Kantarci, Mehmet Eyuboglu, Dilsad
Amanvermez Senarslan
From: Cardiovascular Journal of Africa, Vol 28,
Issue 4, July/August
Published: 2017
Pages:e9-e11
Full text: Click here to order
»
Full text:
Click here to read online »
Full text: Click here to
read via Sabinet » (Login Required)
DOI Number: 10.5830/CVJA-2016-090
DOI Citation Reference Link:
dx.doi.org/10.5830/CVJA-2016-090
Abstract: Dissecting intra-myocardial haematoma
is a rare disease and a potentially fatal
complication after cardiac surgery. Patients
with previous heart surgery have more risk for
dissecting intra-myocardial haematoma after
percutaneous coronary intervention. Management
of this issue is challenging. We describe a rare
case of a 63-year-old woman with a left
ventricular wall-dissecting intra-myocardial
haematoma, which developed 30 minutes after
percutaneous coronary intervention. The patient
was treated conservatively, with a successful
outcome.